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Healthcare professionals recommend many methods of restorative and therapeutic 
treatments, such as medicine, surgery, radiation, and rehabilitation to treat chronic diseases and 
conditions. However, evidence suggests that cultivating stem cells from permanent and 
deciduous teeth are an effective method to treat many oral and systemic conditions. There is a 
greater advantage to using stem cells from human exfoliated teeth (SHED) because of their 
differentiating capabilities, which allows for them to have diverse clinical applications. 
Deciduous teeth are often discarded after they are shed from the oral cavity, which reduces the 
likelihood of ethical considerations. In addition, stem cells obtained from teeth replicate at a 
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quicker rate and for a longer period of time than other types of stem cells from the body. The 
process of isolating SHED is relatively uncomplicated and unlikely to generate pain. 
Additionally, since the transplant is obtained from the same individual, the individual does not 
demonstrate adverse immune reactions or rejections. The host and recipient are the same; 
therefore, the person is a 100% match to the stem cell. Hence, when compared to other types of 
adult stem cell harvesting, acquiring stem cells from deciduous teeth is noninvasive. SHED 
demonstrates great potential in treating patients with periodontal disease, namely reducing 
gingival bleeding, increasing new attachment of the periodontal ligament, and decreasing pocket 
depths. Oral healthcare providers should consider recommending SHED in their clinical practice 
due to their multi-differentiation potential, self-renewal capacity, and reported ease of the 
procedure. Further research is needed on the potential impact of regenerative therapies on 
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Healthcare professionals recommend many methods of restorative and therapeutic 
treatments, such as medicine, surgery, radiation, and rehabilitation to treat chronic diseases and 
conditions. However, in 1868 the term “stem cell” was first introduced by a German biologist 
named Haeckel. In 1908 a Russian histologist, Alexander Maksimov who discovered the use of 
stem cells.1 It was then that stem cells were declared for scientific use.1 Growing evidence has 
shown that stem cells have confounding therapeutic abilities in orofacial, neurologic, corneal, 
cardiovascular, hepatic, diabetic, renal, muscular auto-immune conditions.2 
A recent development in stem cell research has been the discovery of dental stem cell 
harvesting as a noninvasive method to treat various health conditions. Not only can stem cells 
from human exfoliated deciduous teeth (SHED) help treat many dental diseases, such as 
periodontal disease, they can also be used to establish normal function in many other organs. 
SHED has the potential to regenerate human cells and tissues, important in regenerative 
medicine. These therapies have the potential for clinical applications in numerous diseases.2 The 
approach of stem cell harvesting has shown less legal implications due to the natural exfoliation 
of one’s teeth. SHED has been used in bone regeneration for periodontal disease, diabetes, acute 
renal failure, Alzheimer's disease, and many others.2 Therefore, SHED shows promising 




1. CURRENT SCIENCE REGARDING STEM CELL RESEARCH AND 
DECIDUOUS TEETH 
Human deciduous teeth are altogether not the same as permanent teeth with respect to 
developing cycles, tissue structure, and function.3 Dental pulp from permanent teeth stem cells 
are adult dental pulp stem cells (DPSC) and deciduous teeth stem cells are stem cells from 
human exfoliated deciduous teeth (SHED). Cultivating stem cells from permanent and deciduous 
teeth differ in numerous points of view. Multiple studies have shown that SHED has greater 
proliferation and survival rates than DPSC, but there are not any functional differences between 
DPSC and SHED because they both have the capability to proliferate into soft and hard tooth 
tissues such as, endothelial cells and dentin secreting odontoblasts which are both important cells 
to regenerate damaged teeth.4,5 
In 2019, Naz et al. found that SHEDs growth rate was the first cell to be able to culture in 
approximately 4 to 16 days while the DPSCs cells took 9 to 16 days.4 Naz et al. also used a 
trypan blue dye to test the integrity of SHED’s and DPSC’s cell membrane and it showed that for 
SHED it was a 94.19 +/- 1.65% viability and for DPSC it was a 99.4 +/- 0.9% viability.4 This 
study shows that DPSC and SHED have the capability to be able to regenerate into bone and 
cartilage by differentiating into odontoblast like cells and produce dentin from the enzymatic 
method in vivo.4 By using the enzymatic method, it shows there is a greater advantage because it 
releases multiple different types of cells that are able to regenerate in the dental pulp tissue.4 
In spite the fact that stem cells share comparative properties, the stem cells vivo 
experiment, developmental, and restorative potential are desired for their undeveloped start and 
their possible anatomic location.3 Teeth develop from oral ectoderm and neural-crest 
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mesenchyme cells which are the epithelial components of the stem cells for continuously 
growing teeth that form from tissue layers. 3 The oral ectoderm and neural-crest mesenchyme 
cells compared to the embryonic stem cells show that they have similar pluripotent development 
because they are able to differentiate into many different cells types such as glia, neurons, bones, 
tendons, melanocytes, chondrocytes, endocrine cells, adipose cells, and many others.3 The neural 
crest cells are the most wanted stem cells because they do not have a restriction capacity or a 
limiting number as the embryonic stem cells do. The deciduous teeth stem cells have the 
clonogenicity, self-renewal and proliferation capacity, expression pattern of specific markers, 
and multipotency that is needed for the use of cultivating and regenerating for the use of other 
types of medical treatment.3 
The stem cells niche (SCN) is a remarkable microenvironment inside each tissue that 
directs stem/progenitor cell multiplication, endurance, relocation, destiny, and maturing, through 
explicit connection between the cells and through different bioactive atoms. 3 The development 
of deciduous teeth stem cells starts before birth and is continued up until eruption of the 
permanent teeth.3 During the period of developing deciduous teeth stem cells they are not 
affected by genetic or environmental factors; therefore, deciduous teeth stem cells provide a 
great source of healthy stem cells that can be used for cultivating and regenerating for the use of 
medical treatments when compared to the permanent teeth stem cells.3 
Stem cell banking of bone marrow and placental cord blood has been available for 
decades with one of the world’s first dental stem cell banks starting in 2004 at Hiroshima 
University in Japan.5 Recently the United States, United Kingdom, and India have also started 
specializing in stem cell banking of teeth. Within the United States there are several places that 
have stem cell banking companies such as New York (StemSave), Indiana (Tooth Bank), and 
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Massachusetts (NDPL - National Dental Pulp Lab). These companies can still provide services 
anywhere in the United States through a collection kit that is mailed to the donor then shipped 
back to the stem cell bank overnight. The stem cell banking company will hold the viable cells 
and pulp tissue for as long as the donor is paying the annual or monthly storage fees. The annual 
cost to store the viable cells and pulp tissue can range from $115 to $600 or $1,500 to $2,500 if 
the donor would like to pre-purchase a 20-year storage plan. The banking companies also have 
an initial enrollment and processing fee that cost about $600.  
With dental stem cell banking, there are many types of different protocols to follow for 
the sampling process. Most of the dental stem cell banking services recommend that dentists 
extract the deciduous tooth as soon as it becomes loose.5 After the deciduous tooth is extracted or 
exfoliated, the tooth needs to be placed in a transport medium containing pasteurized bovine 
milk. The storage process has the biggest impact on keeping the pulp living for cultivating stem 
cells.5 Once the tooth is out of the oral cavity and placed into the milk, it only has up to 48 hours 
before the tooth becomes non-vital for cultivating.5 Bovine milk is one of the most recommended 
types of transport mediums for a tooth because of its biocompatibility, neutral pH, and naturally 
buffering properties.5 Other types of transport medium such as soy milk or almond milk are not 
as ideal.5 In order for the viable cells and pulp tissue to be successfully isolated, they must go 
through a process called cryopreservation which consists of extracting the viable cells and pulp 
tissue from the tooth and storing them in a frozen compartment with liquid nitrogen within the 




2. LEGAL AND ETHICAL IMPLICATIONS 
There has been a large amount of controversy regarding the stem cell harvesting of 
embryonic stem cells due to personal and moral beliefs; however, cultivating stem cells from 
exfoliated teeth can alleviate some of these concerns. The derived embryonic stem cells are 
collected at a developmental stage prior to the time that implantation would occur in the uterus.5 
Fertilization typically occurs in the oviduct, and after a few days a series of mitotic divisions 
occur as the embryo travels along the fallopian tube into the uterus.5 During this stage of mitotic 
division the blastomeres are not defined to any certain type of cell.5  In fact, each of these cells 
can take on any form of cell.9 Induced pluripotent stem cells (iPSCs) can be obtained from the 
inner cell mass of within about a week by blastomere cells.6 This is where the ethical and 
political controversy regarding human embryonic stem cells (hESC) is a concern due to the 
possible destruction of human embryos and the different opinions on when human life begins.7 
The alternative to stem cell research is the harvesting of stem cells through exfoliated 
deciduous teeth. The deciduous teeth are discarded after they are shed from the oral cavity; 
therefore, this reduces the likelihood of ethical considerations.3,8 Isolation of the dental pulp, 
retrieving stem cells, manipulating, and expanding cells in vitro is a straightforward process.3 
The majority of humans lose their teeth; therefore, creating an ideal opportunity to retrieve and 
store this source of stem cells.8 In addition, stem cells obtained from teeth replicate at a quicker 
rate and for a longer period of time than other types of stem cells from the body.8 Another 
benefit of dental stem cells from deciduous is that there are multiple opportunities to obtain the 
stem cells.8 The process of isolating SHED stem cells is not difficult and unlikely to generate 
pain, and since the transplant is obtained from the same individual they do not demonstrate 
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immune reactions or rejections.1 The host and recipient are the same; therefore, the person is a 
100% match to the stem cell. Hence, when compared to other types of stem cell harvesting 
methods, acquiring stem cells from teeth is noninvasive, not as dependent on timing, and much 
less expensive unlike embryonic stem cell harvesting.8 
An associated concern of stem cell harvesting is the use of these stem cells for 
therapeutic cloning. Therapeutic cloning can be defined as the transfer of nuclear material from a 
somatic cell into an enucleated oocyte with the objective of obtaining embryonic stem cells that 
have the same genome as the donor.9 The purpose for therapeutic cloning is to allow an 
individual's own cell, isolated from an embryo that is not planned to transfer into the uterus, to be 
used for regenerative and reproductive medicine.9 This is not the same thing as reproductive 
cloning, where one is trying to create a person.9 However, laws regarding therapeutic cloning and 
reproductive cloning are vague, making it difficult to differentiate between the two types. The 
ethical considerations of therapeutic cloning come from the source of embryonic stem cells, from 
aborted fetuses, unused zygotes, and the embryos that are unable to implant themselves in utero.9 
However, there is no supporting research tying the use of SHED or hDPSCs to therapeutic 
cloning. Therefore, this can reduce the associated apprehension of harvesting dental stem cells 
for other therapeutic reasons. 
The emergence of SHED and hDPSCs have grown in popularity as a source for bone 
regeneration.10 However, there is still no clear evidence on the types of teeth and the condition of 
the teeth most acceptable for stem cell isolation.10 Nakajima conducted an in vitro study at 
Hiroshima University to test the success rate of SHED and hDPSCs. The successful isolation of 
SHED and hDPSCs appears to be associated with the age of the patient, the length of the 
remaining root, and the mechanical forces.10 In the study, they used extracted permanent teeth 
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from two canines, twelve premolars, and six wisdom teeth to obtain the periodontal tissue.10 
They also used exfoliated deciduous periodontal tissue from six incisors, ten canines, and six 
molars.10 The results from isolation of SHED was successful in 18 out of 22 exfoliated deciduous 
teeth (82%), and hDPSCs was successfully isolated from 14 out of 20 permanent teeth extracted 
(70%).10 
In 2017, Tsai et al. conducted an in vitro study to identify predictors of success rate of 
mesenchymal stem cell (MSC) isolation from deciduous teeth pulp.9 The study was conducted 
using 161 deciduous teeth that were extracted at the pediatric dental clinic, the dental pulps were 
harvested using standard protocol.9 In the study, the researchers collected four types of teeth: 
incisors, canines, molars, and supernumerary teeth.9 They examined whether the tooth was 
present with caries or not and the severity of the caries.9 Lastly, the pulp status was collected  to 
determine if the tooth was present with pulpitis or non-present with pulpitis (yes/no).9 In this 
study, 128 colonies of MSCs were acquired out of the 161 deciduous teeth, and the results 
showed a success rate of 79.5%.9 The study found that the deciduous teeth that successfully 
yielded MSCs had less dental caries (P < 0.001) and they had less prevalence of pulpitis (P 
<0.001).9 In conclusion, the deciduous teeth that were not present with dental caries and pulpitis 




3. APPLICATION TO PATIENT CARE AND/OR TREATMENT 
MODALITIES 
Periodontitis is a common inflammatory disease affecting 15-50% of adults in developed 
countries.6,11 Periodontitis is caused by infection of the periodontium, tissue inflammation, and 
excessive immune response to the oral bacteria, eventually leading to bone loss.11 Consequently, 
periodontitis can lead to tooth loss if left untreated and therefore affects quality of life in these 
patients.11 In 2018, Gao et al explained that multidose SHEDs resulted in periodontal tissue 
regeneration. In an induced periodontitis model, multidose of SHED was delivered in 7-day 
intervals. Results showed that SHED reduced gingival bleeding, increased new attachment of the 
periodontal ligament, decreased the differentiation of osteoclasts in the periodontium, and 
decreased pocket depths.11 The results demonstrated a p-value of P<0.05 and is considered to be 
statistically significant.11 
Cleft lip and palate are other conditions that have been treated with bone 
regeneration. Iliac bone and alveolar bone grafting are some examples of the conventional 
approaches in bone regeneration. These types of procedures have been shown to be quite 
invasive and have been associated with many complications, such as, scarring, fracture of the 
iliac bone, infection, and hematoma.12 Harvesting SHED for bone regeneration is less invasive 
compared to conventional approaches and is therefore an accessible and promising tool in 
regenerating bone in cleft lip and palate patients.12 
SHED also has the capability to form into pulp-like structures which may be useful in 
treating pulpitis or promoting restoration of pulp vitality.13 In 2017, Li et al demonstrated that 
SHED can proliferate into dentin cells and endothelial cells. In this study, SHED was placed in a 
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full-length human root canal and placed directly under the skin of nude mice.13 The results were 
that SHED proliferated into functional dentin cells similar to that of normal dental pulp 
cells.13 However, this study has only been done ectopically on mice models and further studies 
need to be conducted within the oral cavity in order to fully explore the ability of SHED.13 
Dental pulp stem cells, specifically SHED, have shown great potential in not only dental 
medicine but also in many other fields of medicine.2 Regenerative therapies from stem cells have 
been studied by scientists over the past three decades in hopes of finding minimally invasive 
medical treatments for patients with systemic diseases such as diabetes, acute renal failure, 
Alzheimer’s disease, and many others.2 SHEDS have shown high multi-differentiation potential, 
compared to DPSCs and other types of stem cells, and therefore can be used to regenerate 
different types of tissue.2 SHEDS are also easily accessible and there is no need for 
immunosuppressive drugs because there is typically no immune rejection during 
transplantation.2,13,14,15 
Repairing the nervous system is limited and there are very few procedures that are able to 
repair it structurally and functionally. In turn, there are few treatment options for patients with 
neurological diseases such as Parkinson’s and Alzheimer’s disease. In 2017, Li et al conducted a 
study in which SHED was injected in a rat model with Parkinson’s disease.13 In this study, 36 
female rats with Parkinson’s disease were placed into three random groups. One group was the 
negative control group, one group was injected with in-tact SHED, and one group was injected 
with SHED-derived spheres created in vitro, similar to neural crest cells. Within two weeks, the 
rat models showed behavior improvement and recovery that was sustained for up to six 
weeks. This study successfully demonstrates that SHED can differentiate into neuron-like cells 
and can be used therapeutically to improve neural function.16 Similarly, in rats that experienced 
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spinal cord injury, SHED injections helped improve motor functions due to the stem cells and the 
common embryonic developmental origin with cells in the nervous system.13 Animal behavior 
was analyzed using a one-way analysis of variance (ANOVA, SPSS software) and then 
compared using Bonferroni (Dunn) comparison groups.16 The results demonstrated a p-value of 
P<0.01 and is considered to be statistically significant.16 
In 2012, Kerkis and Caplan conducted a study in which systemic and local delivery of 
SHED was given to dog models with Duchenne muscular dystrophy.14 Six golden retriever 
muscular dystrophy (GRMD) dogs were given both local and systemic delivery of the stem 
cells.6 Giving the dogs SHED intravenously showed less of an immune response than when 
given directly into the muscle by injection.2 The effect of the paracrine system in these models 
triggered overall regenerative processes to begin to take place by progenitor stem cells which 
improved function in these dogs. This treatment effect may also be useful in patients with other 
autoimmune diseases that have few treatment options.2 However, studies conducted with a larger 
sample size and potential human models need to be done in order to show validity of the results 
in this study.14 
SHEDs show excellent immunomodulatory effects compared to other types of stem cells 
and therefore have been studied in therapies for autoimmune diseases.13.17 Infusion of SHED 
showed a significant increase of Treg cells and decrease of T helper 17 cells. Treg cells prevent 
autoimmunity and T helper 17 cells promote autoimmunity and inflammation.17 Therefore, 
SHED may be useful in treating autoimmune diseases and improving immunomodulatory 
properties.17 These properties were studied in mice models with systemic lupus erythematous 
(SLE). SLE is an immune disease that destroys targeted organs such as the kidneys, joints, 
cardiovascular system, and nervous system.17 The disease induces both deficiency in immune 
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reactions as well as hyperactivity of the immune system.3 Transplantation of SHED in these mice 
reversed the effects of SLE by reducing inflammation caused by T helper 17 cells in the blood. It 
also helped in reconstruction of trabecular bone and inhibited the action of osteoclasts which can 
improve the effects of SLE.3 This study showed that the use of SHEDS showed promising 
potential in the therapeutic effects of stem cells compared to bone marrow mesenchymal stem 
cells.3 This suggests that SHEDS can provide another treatment option in those with immune 
diseases.3,13 However, more studies need to be conducted in order to further investigate the 





In conclusion, studies have shown there are many uses for deciduous teeth stem cells in 
not only dentistry but the medical field as well.1,2,3,11,13,14,15,17,18 Deciduous teeth stem cells have 
the clonogenicity, self-renewal and proliferation capacity, expression pattern of specific markers, 
and multipotency that is needed for the use of cultivating and regenerating for the use of other 
types of medical treatment.3 Compared to other types of stem cell harvesting, such as bone 
marrow stem cells, SHED has shown no ethical controversy or considerations due to the 
noninvasive way of harvesting them.8 Dental clinicians must treat patients as a whole and be 
aware of their overall health and wellbeing. Patients with systemic diseases such as diabetes, 
Alzheimer’s disease, or lupus experience manifestations that affect their oral health. 
Understanding and further researching treatment options provided by deciduous teeth stem cells 
can greatly benefit our patients. Most studies conducted have been in-vitro studies completed on 
animal models. Therefore, further research needs to be conducted on human models and with 
larger sample sizes in order to validate the effectiveness of SHED. SHED show great potential 
for new therapies in the clinical setting due to their multi-differentiation potential, self-renewal 
capacity, and the reported ease of accessibility in acquiring stem cells from human deciduous 
teeth.2 Therefore, clinicians should consider further researching these types of regenerative 
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